← Open Payments lookup

MAURICE FIEDEL: Open Payments

NPI 1265035257 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$947 in 49 payments from 11 companies in 2025. Trend: 2023 $868 · 2024 $873 · 2025 $947

Food & beverage: $947
CompanyPaymentsAmount
ABBVIE INC.13$282
Teva Pharmaceuticals USA, Inc.12$154
Neurocrine BioSciences, Inc.5$112
E.R. Squibb & Sons, L.L.C.5$81
Alkermes, Inc.3$74
Janssen Pharmaceuticals, Inc3$74
Takeda Pharmaceuticals U.S.A., Inc.2$60
Axsome Therapeutics, Inc.2$38
Lundbeck LLC2$36
Otsuka America Pharmaceutical, Inc.1$19

Products named: VRAYLAR, AUSTEDO XR, INGREZZA, COBENFY, TRINTELLIX, REXULTI, INVEGA SUSTENNA, ARISTADA.

Industry payments across UT — which companies pay providers there.